参考文献/References:
[1] ZHAO D W,YU M,HU K,et al.Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population:results from a nationally representative survey[J].Chin Med J(Engl),2015,128(21):2843-2850.
[2] 唐涛,苟远涛,唐俊,等.成都地区成人股骨头坏死流行病学研究[J].中国康复理论与实践,2018,24(8):970-974.
[3] MONT M A,HUNGERFORD D S.Non-traumatic avascular necrosis of the femoral head[J].J Bone Joint Surg Am,1995,77(3):459-474.
[4] GARDENIERS J W M.Report of the committee of staging and nomenclature[EB/OL].(1993-10-14)[2019-08-03].http://arco-intl.org/Newsletters/Gardeniers-1993-5-2/Gardeniers-1993.htm.
[5] 李子荣,刘朝晖,孙伟,等.基于三柱结构的股骨头坏死分型——中日友好医院分型[J].中华骨科杂志,2012,32(6):515-520.
[6] 陈卫衡,刘道兵,张洪美,等.股骨头坏死的三期四型辨证思路[J].中国中医基础医学杂志,2003,9(12):51-52.
[7] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:193.
[8] 何伟.精确诊断前提下股骨头坏死非手术治疗实践[J].临床外科杂志,2017,25(8):580-582.
[9] 何伟,洪郭驹,张庆文,等.非创伤性股骨头坏死中医辨病相关古籍文献内容评析[J].时珍国医国药,2016,27(3):659-660.
[10] 吴红富,王晶,张斌,等.石氏伤科治疗激素性股骨头坏死经验初探[J].中华中医药杂志,2019,34(8):3541-3543.
[11] 张俐.中医骨病学[M].北京:人民卫生出版社,2012:116-127.
[12] 王和鸣.中医骨伤科学[M].北京:中国中医药出版社,2017:338-340.
[13] 李泰贤,陈志伟,王荣田,等.基于文献计量学分析中医药治疗股骨头坏死的研究现状[J].中国中医骨伤科杂志,2017,25(4):41-46.
[14] 中华中医药学会.股骨头坏死中医辨证标准(2019年版)[J].中医正骨,2019,31(6):1-2.
[15] 连曦敏,张一平.成人股骨头缺血性坏死介入治疗的价值探讨[J].中国现代药物应用,2010,4(24):25-26.
[16] 尹啸飞,周正新.中医药治疗股骨头坏死临床研究进展[J].辽宁中医药大学学报,2018,20(2):218-220.
相似文献/References:
[1]陈雷雷,张颖.何伟教授采用中医药疗法治疗股骨头坏死的经验[J].中医正骨,2015,27(10):74.
[2]徐西林,赵永兰,张晓峰,等.活骨注射液髋关节腔灌注对兔股骨头坏死模型
血管内皮生长因子表达的动态影响[J].中医正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):1.
[3]周勇,任菲菲,丰凡翔,等.血管内皮生长因子和骨形态发生蛋白2
在非创伤性股骨头坏死不同区域的表达[J].中医正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):7.
[4]鲍荣华,王国平,夏晓斌,等.钽棒植入治疗非创伤性股骨头坏死的疗效观察[J].中医正骨,2015,27(02):28.
[5]张兵,马凰富,刘波,等.非创伤性股骨头坏死的舌象定量研究[J].中医正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):8.
[6]李刚,程春生.股骨头坏死血瘀证症状与平乐郭氏正骨方药药物组成
最大频繁关联模式挖掘[J].中医正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):21.
[7]李文龙,梅沉成,杜贵强,等.微创减压植骨多孔钽棒植入治疗
ARCOⅡ期非创伤性缺血性股骨头坏死[J].中医正骨,2016,28(02):43.
[8]张磊,金红婷,童培建.骨健口服液早期干预非创伤性股骨头坏死的临床研究[J].中医正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):14.
[9]鲍荣华,王国平,夏晓斌,等.直接前入路微创全髋关节置换术治疗晚期股骨头坏死[J].中医正骨,2016,28(03):61.
[10]张超,姚晨,沈计荣.微创髓芯减压打压支撑植骨术结合补肾活血汤口服治疗ARCOⅡ、Ⅲ期股骨头坏死的近期疗效观察[J].中医正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):20.
[11]陈卫衡.中国股骨头坏死数据库的现状与挑战[J].中医正骨,2020,32(01):1.
[12]雷志强,曾平,陈卫衡,等.中国股骨头坏死数据库股骨头坏死流行病学特点分析[J].中医正骨,2020,32(01):4.
[13]周占国,郭浩山,关涛,等.股骨头坏死病因的相关因素分析[J].中医正骨,2020,32(01):7.
[14]陈瑞,董博,袁普卫,等.股骨头坏死误诊原因分析[J].中医正骨,2020,32(01):11.
[15]杨琪,杜炯,孙继高,等.股骨头坏死中医证型分析[J].中医正骨,2020,32(01):14.
[16]庄至坤,郭金花,赵岩,等.股骨头坏死髋关节疼痛和活动度与ARCO分期的相关性分析[J].中医正骨,2020,32(01):21.
[17]范亚楠,李文龙,张颖,等.不同病因股骨头坏死的ARCO分期和中日友好医院分型特征研究[J].中医正骨,2020,32(01):25.
[18]高欢欢,王向鹏,任浩,等.股骨头坏死的舌象特征研究[J].中医正骨,2020,32(01):28.
[19]薛志鹏,李记天,高欢欢,等.股骨头坏死舌象特点的聚类分析[J].中医正骨,2020,32(01):32.
[20]宋梦歌,李记天,薛志鹏,等.股骨头坏死保髋治疗的临床疗效分析[J].中医正骨,2020,32(01):36.